Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04857060 · ClinicalTrials.gov registry record · NA
Palliative Care Educator
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 11,174
- Enrollment target
NCT04857060: Completed NA study, sponsored by Tufts Medical Center.
NCT04857060 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 11,174 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (696% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04857060, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,174 participants
- Enrollment target
Study Summary
The investigators propose to conduct a stepped wedge cluster randomized trial of an advance care planning (ACP) educator-led intervention among hospitalized patients aged 65 and over, or any patient with Alzheimer's Disease and Related Dementias (ADRD) and their proxy decision-makers in the ward and ICU settings of two major hospitals: Boston Medical Center and North Shore University Hospital in New York. Patient outcomes will be abstracted from electronic health records with Natural Language Processing. The effectiveness of the intervention will be evaluated by comparing the following outcomes among 9,000 hospitalized patients (Aim 1): ACP documentation; preferences for resuscitation; palliative care consults; and, hospice use. The investigators will characterize caregiver-centered outcomes of patients with ADRD, including (Aim 2): (1) knowledge, (2) confidence in future care, (3) communication satisfaction, and (4) decisional certainty in 600 caregivers of patients with ADRD admitted to the hospital. COVID-19 poses a unique dilemma for older Americans and patients with ADRD and their caregivers, who must balance their desire to live against the risk of a lonely and potentially traumatic hospital death. Video decision support is a practical, evidence-based, and innovative approach to assist patients facing such choices. If proven effective, this innovative care model can be immediately deployed across the country to improve the quality of care for millions of Americans.
Primary Outcome
Any documentation of a discussion pertaining to limitations of life sustaining treatment, palliative care, hospice, goals of care, time-limited trial, or surrogate decision makers.
Interventions
- BEHAVIORAL ACP Educator led, video assisted discussion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,174 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
What the finished NCT04857060 record still lists
NCT04857060 is an interventional study that assigns participants to a tested intervention. Its 11,174 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (696% higher).
The record links to 0 conditions, and to 1 intervention - of which ACP Educator led, video assisted discussion is the first listed.
NCT04857060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04857060 about?
NCT04857060 is a clinical study titled "Palliative Care Educator". The investigators propose to conduct a stepped wedge cluster randomized trial of an advance care planning (ACP) educator-led intervention among hospitalized patients aged 65 and over, or any patient with Alzheimer's Disease and Related Dementias (ADRD) and their proxy decision-makers in the ward and...
What is the current status of trial NCT04857060?
This trial is currently completed. It is a NA study. The enrollment target is 11,174 participants. The study started on 2021-07-01. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT04857060?
The interventions under investigation include: ACP Educator led, video assisted discussion (BEHAVIORAL).
Who is sponsoring clinical trial NCT04857060?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04857060's enrollment target sits among peer trials
11,174 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06677060 · 11,300 participants · Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- NCT07181109 · 11,000 participants · Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI